Parity and age at first childbirth in relation to the risk of different breast cancer subgroups

被引:40
作者
Butt, Salma [1 ,2 ]
Borgquist, Signe [3 ,4 ]
Anagnostaki, Lola [3 ]
Landberg, Goran [3 ]
Manjer, Jonas [1 ,2 ]
机构
[1] Malmo Univ Hosp, Dept Surg, S-20502 Malmo, Sweden
[2] Malmo Univ Hosp, Malmo Diet & Canc Study, S-20502 Malmo, Sweden
[3] Malmo Univ Hosp, Ctr Mol Pathol, Dept Lab Med, S-20502 Malmo, Sweden
[4] Univ Lund Hosp, Div Oncol, Dept Clin Sci, S-22185 Lund, Sweden
关键词
breast cancer risk; parity; age at diagnosis; stage; subgroups; REPRODUCTIVE FACTORS; HORMONE-RECEPTOR; PREGNANCY; BIRTH; TIME; ASSOCIATION; PROGNOSIS; MORTALITY; SURVIVAL; COHORT;
D O I
10.1002/ijc.24494
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
The aim of the present study was to examine parity and age at first childbirth, in relation to the risk of specific breast cancer subgroups. A prospective cohort, The Malmo Diet and Cancer Study, including 17,035 women were followed with linkage to Swedish Cancer Registry until December 31, 2004. A total of 622 incident breast cancers were diagnosed during follow-up and were evaluated regarding invasiveness, tumour size, axillary lymph node status, Nottingham grade, tumour proliferation (Ki67), HER2, cyclin D1 and p27. The tumours were also examined for WHO type and hormone receptor status. Nulliparity was associated with an overall increased risk of breast cancer, although not statistically significant (the relative risk was 1.39 with a 95% confidence interval of 0.92-2.08). Nulliparity was also associated with large tumours (>20 mm) (1.89: 0.91-3.91), high Ki67 levels (1.95: 0.93-4.10), high cyclin D1 levels (2.15: 0.88-5.27) grade III (2.93: 1.29-6.64) and HER2 positive tumours (3.24, 1.02-10.25). High parity was not statistically significantly associated with any specific breast cancer subgroup. Older age at first childbirth (>30) was associated with a slightly increased risk of breast cancer (1.39: 0.94-2.07). There was a statistically significant association between late first childbirth and lobular type (2.51: 1.01-6.28), grade III tumours (2.67: 1.19-6.02), high levels of cyclin D1 (2.69: 1.18-6.12) and low levels of p27 (2.23: 1.15-4.35). We conclude that nulliparity and late first childbirth are associated with relatively more aggressive breast cancer subgroups. (C) 2009 UICC
引用
收藏
页码:1926 / 1934
页数:9
相关论文
共 36 条
[1]
Clinical stage of breast cancer by parity, age at birth, and time since birth:: a progressive effect of pregnancy hormones? [J].
Albrektsen, G ;
Heuch, I ;
Thoresen, S ;
Kvåle, G .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2006, 15 (01) :65-69
[2]
Breast cancer risk by age at birth, time since birth and time intervals between births:: exploring interaction effects [J].
Albrektsen, G ;
Heuch, I ;
Hansen, S ;
Kvåle, G .
BRITISH JOURNAL OF CANCER, 2005, 92 (01) :167-175
[3]
BREAST-CANCER INCIDENCE BEFORE AGE-55 IN RELATION TO PARITY AND AGE AT FIRST AND LAST BIRTHS - A PROSPECTIVE-STUDY OF ONE MILLION NORWEGIAN WOMEN [J].
ALBREKTSEN, G ;
HEUCH, I ;
TRETLI, S ;
KVALE, G .
EPIDEMIOLOGY, 1994, 5 (06) :604-611
[4]
Family history of breast cancer and short-term effects of childbirths on breast cancer risk [J].
Albrektsen, Grethe ;
Heuch, Ivar ;
Thoresen, Steinar ;
Kvale, Gunnar .
INTERNATIONAL JOURNAL OF CANCER, 2006, 119 (06) :1468-1474
[5]
Diet and body constitution in relation to subgroups of breast cancer defined by tumour grade, proliferation and key cell cycle regulators [J].
Borgquist, Signe ;
Wirfalt, Elisabet ;
Jirstrom, Karin ;
Anagnostaki, Lola ;
Gullberg, Bo ;
Berglund, Goran ;
Manjer, Jonas ;
Landberg, Goran .
BREAST CANCER RESEARCH, 2007, 9 (01)
[6]
Breast tumours following combined hormone replacement therapy express favourable prognostic factors [J].
Borgquist, Signe ;
Anagnostaki, Lola ;
Jirstrom, Karin ;
Landberg, Goran ;
Manjer, Jonas .
INTERNATIONAL JOURNAL OF CANCER, 2007, 120 (10) :2202-2207
[7]
Pregnancy and the risk of breast cancer [J].
Britt, Kara ;
Ashworth, Alan ;
Smalley, Matthew .
ENDOCRINE-RELATED CANCER, 2007, 14 (04) :907-933
[8]
BRITTAIN AW, 1991, SOC BIOL, V38, P219
[9]
Parity in relation to survival following breast cancer [J].
Butt, S. ;
Borgquist, S. ;
Garne, J. P. ;
Landberg, G. ;
Tengrup, I. ;
Olsson, A. ;
Manjer, J. .
EJSO, 2009, 35 (07) :702-708
[10]
Validation of tissue microarray technology in breast carcinoma [J].
Camp, RL ;
Charette, LA ;
Rimm, DL .
LABORATORY INVESTIGATION, 2000, 80 (12) :1943-1949